ORTEXORTEX News
Tracking BMI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
BM
ConfluenceBMI

Badger Meter options hit 52-week bearish extreme after earnings pop

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 29 Oct 2026, 13:19

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

BMI stands out as one of the more heavily shorted names in its peer group. Short interest sits at 14.8% of free float, well above ITRI, its closest correlated peer. Among the broader electronic equipment and instruments sector, that level places BMI near the top of the crowding table.

The more striking development is in options. The put-call ratio hit 2.18 on October 28, the highest reading in 52 weeks and a 52-week high by some distance from the prior floor of 0.07. At 3.1 standard deviations above the 20-day average of 1.42, protective put demand is running at its most extreme in at least a year. The timing is notable: BMI shares jumped 14.7% on October 22 after a strong earnings print, then gave back 5.1% on October 28. Options traders appear unconvinced the rally holds.

Analysts split on the earnings bounce

The post-earnings move drew a quick round of analyst reactions. Argus Research upgraded BMI to Buy from Hold on October 27, setting a $170 price target. RBC Capital kept its Outperform and raised its target to $187 from $162 the same week. Stifel raised its Buy target to $168 from $150.

Not everyone followed. Barclays lifted its target only marginally, to $112 from $111, while holding its Underweight rating. The stock closed at $144.05, sitting between the bear and the bull camps. The consensus stands at Buy with a mean target of $165.75, implying roughly 15% upside from current levels.

Retail attention spikes

Wikipedia views and ORTEX stock page traffic placed BMI's retail attention at 4.1 standard deviations above its own 90-day average as of October 26. That kind of attention spike typically accompanies a large price move, and the 23.5% one-week gain through October 26 supplies the obvious cause. It is attention, not a revenue indicator.

On the lending side, availability stands at 159.6%, meaning roughly 1.6 shares are available to borrow for every share already borrowed. The borrow market is not tight. Short interest edged down 6.4% over the past week, suggesting some covering followed the earnings jump.

Data summary

  • SI % of free float: 14.8%, down 6.4% week on week
  • Put-call ratio: 2.18, 52-week high, 3.1 standard deviations above the 20-day mean
  • Availability: 159.6%, loose borrow conditions
  • Cost to borrow: 0.60%, down 6.6% over the past week
  • ORTEX short score: 74.6
  • Price: $144.05, up 9.2% over the past week, down 5.1% on October 28
  • Argus upgraded to Buy with a $170 target; Barclays holds Underweight at $112

The level that would change the picture most cleanly is the Barclays $112 target on one side and the RBC $187 on the other. A sustained move toward either extreme, combined with the current put positioning, would clarify whether the earnings pop is consolidating or reversing.

Stocks in this article

See the live data behind this article on ORTEX.

Open BMI on ORTEX →

How this article was generated

Generated
29 Oct 2026, 13:29
Data as of
29 Oct 2026, 13:19
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.